Taylor Morrison (TMHC) Form 144 Files Notice to Sell 14,002 Shares

Rhea-AI Filing Summary

The filer submitted a Form 144 notice proposing the sale of 14,002 shares of common stock of Taylor Morrison Home Corporation (TMHC) through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $980,140 and total shares outstanding reported as 98,843,205. The proposed approximate sale date is 09/11/2025. The shares were acquired in two employer-related transactions: 9,960 shares from a stock option exercise on 06/15/2023 (paid in cash) and 4,042 shares from restricted stock vesting on 05/23/2024 (compensation). The filer reported no securities sold in the past three months and included the standard representation that they do not possess undisclosed material adverse information.

Positive

• Complete acquisition details provided (dates, methods, and payment nature) for the 14,002 shares
• No securities sold in the past three months, indicating this is an isolated reported sale

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider sale notice for 14,002 TMHC shares; acquisition dates are employee-related and no recent sales were reported.

This Form 144 documents a planned sale through a registered broker on the NYSE with a stated aggregate market value under $1.0 million. The underlying holdings originated from a stock option exercise and restricted stock vesting, both typical compensation events. The filing does not disclose any prior sales in the last three months, which limits near-term sale-by-insider activity evidence. As a compliance notice, it provides disclosure of timing, broker, and acquisition method but no additional financial metrics.

Corporate Governance Expert

TL;DR Disclosure appears procedural and consistent with Rule 144 requirements; no governance red flags are stated.

The notice identifies the broker, planned sale date, and detailed acquisition history for the shares, including that compensation and option exercise funded the positions. The filer affirms absence of undisclosed material adverse information, which is the standard representation on Form 144. The document contains no indications of unusual trading arrangements, clustering of multiple recent sales, or related-party complexities that would be material to governance assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	14002	980140.00	98843205	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2023	Stock Option Exercise	Issuer			9960	06/15/2023	Cash
Common	05/23/2024	Restricted Stock Vesting	Issuer			4042	05/23/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TMHC Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 14,002 TMHC common shares via Fidelity on the NYSE with an aggregate market value of $980,140 and an approximate sale date of 09/11/2025.

How were the TMHC shares being sold acquired?

The shares were acquired as follows: 9,960 from a stock option exercise on 06/15/2023 (paid in cash) and 4,042 from restricted stock vesting on 05/23/2024 (compensation).

Does the Form 144 show recent insider sales for TMHC?

The filer reported Nothing to Report for securities sold during the past three months, indicating no reported insider sales in that period.

Which broker and exchange are named in the TMHC Form 144?

The broker named is Fidelity Brokerage Services LLC located in Smithfield, RI, and the securities are to be sold on the NYSE.

What representation does the filer make regarding material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.